Metabolomics-based Targeted Therapies for Gastric Cancer
- Prosjektnummer
- 90061700
- Ansvarlig person
- Hanne-Line Rabben
- Institusjon
- NTNU, Fakultet for medisin og helsevitenskap, IKOM
- Prosjektkategori
- Doktorgradsstipend
- Helsekategori
- Cancer
- Forskningsaktivitet
- 5. Treatment Developement
Vagotomy and Gastric Tumorigenesis.
Curr Neuropharmacol 2016;14(8):967-972.
PMID: 26791481 - Inngår i doktorgradsavhandlingen
Neural signaling modulates metabolism of gastric cancer
iScience, 2021, DOI: 10.1016/j.isci.2021.102091
Chemopreventive effect of dietary isothiocyanates in animal models of gastric cancer and synergistic anticancer effect with cisplatin in human gastric cancer cells
Frontiers in Pharmacology, 2021, DOI: 10.3389/fphar.2021.613458
Computational drug repositioning and experimental validation of ivermectin in treatment of gastric cancer
Frontiers in Pharmacology, 2021, DOI: 10.3389/fphar.2021.625991
Possible mechanism-of-action of isothiocyanates in chemoprevention and adjuvant chemotherapy for gastric cancer
Gastroenterology 150(4):S110, 2016.
A Potential New Regimen (“TRiCyClE”) for Treatment of Gastric Cancer: Targeting Glutamine-dependent WNT/ß-catenin-mTOR Signaling
Gastroenterology 150(4):S866, 2016
Intragastric Injection of Botulinum Toxin A to Treat Gastric Cancer: An Open-Label Phase II Clinical Trial
Gastroenterology, 150(4):S1251-S1252, 2016
Targeting Nerve-Cancer Metabolism Improved Overall Survival in Aged Mice With Gastric Cancer
Gastroenterology, Gastroenterology 156(6):S-108, 2019
Vagotomy and Gastric Tumorigenesis.
Curr Neuropharmacol 2016;14(8):967-972. PMID: 26791481
A New Treatment for Pancreatic Cancer: Targeting Nervecancer Cell Crosstalk
Gastroenterology, 154(6):S-94, 2018
Intragastric Injection of Botulinum Toxin A to Treat Gastric Cancer: An Open-Label Phase II Clinical Trial
Gastroenterology, 150(4):S1251-S1252, 2016
A Potential New Regimen (“TRiCyClE”) for Treatment of Gastric Cancer: Targeting Glutamine-dependent WNT/ß-catenin-mTOR Signaling
Gastroenterology 150(4):S866, 2016
Possible mechanism-of-action of isothiocyanates in chemoprevention and adjuvant chemotherapy for gastric cancer
Gastroenterology 150(4):S110, 2016.
- Masahiko Nakamura Prosjektdeltaker
- Anders Øverby Prosjektdeltaker
- Magnus Kringstad Olsen Prosjektdeltaker
- Duan Chen Medveileder, biveileder
- Chun-Mei Zhao Prosjektleder
- Hanne-Line Rabben Doktorgradsstipendiat
- Timothy C. Wang Prosjektdeltaker
- Jon Erik Grønbech Prosjektdeltaker
- Steinar Lundgren Prosjektdeltaker
- Gøran Troseth Andersen Prosjektdeltaker
- Atle Magnar Bones Prosjektdeltaker
- Yosuke Kodama Prosjektdeltaker
- Aleksandr Ianevski Prosjektdeltaker
- Denis Kainov Prosjektdeltaker
- Xing Cai Prosjektdeltaker
- James G. Fox Prosjektdeltaker
- Sureshkumar Muthupalani Prosjektdeltaker
- Yoku Hayakawa Prosjektdeltaker
- Hidenori Matsui Prosjektdeltaker
- Tetsufumi Takahashi Prosjektdeltaker
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Helse Midt-Norge RHF - Samarbeidsorganet og FFU